Condensed Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Cash flows from operating activities:
Net loss	$ (14,677,582)	$ (13,692,944)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	227,371	202,971
Amortization	29,464	12,173
Amortization of right-of-use assets	386,198	438,601
Share-based compensation expense	723,722	310,004
Loss on property and equipment dispositions	53,173	0
Amortization of debt issuance costs and discount	1,173,153	854,902
Changes in operating assets and liabilities:
Accounts receivable	(83,826)	(279,384)
Inventory	(2,737,651)	(1,270,552)
Prepaid and other assets	283,382	(266,518)
Accounts payable	656,403	(51,799)
Accrued expenses	(122,588)	(316,651)
Lease liabilities	(392,850)	(273,734)
Other liabilities	(23,694)	(36,509)
Net cash used in operating activities	(14,505,325)	(14,369,440)
Cash flows from investing activities:
Acquisition of patents	(48,216)	(82,237)
Purchases of property and equipment	(385,167)	(654,914)
Net cash used in investing activities	(433,383)	(737,151)
Cash flows from financing activities:
Proceeds from at-the-market sales of common stock	5,496,791	1,021,994
Issuance costs for at-the-market sales of common stock	(164,904)	(30,660)
Proceeds from common stock issued through ESPP	40,875	10,390
Proceeds from the exercise of pre-funded warrants	429	0
Repayment of note payable	(90,961)	0
Net cash provided by financing activities	16,055,985	1,001,724
Net change in cash and cash equivalents	1,117,277	(14,104,867)
Cash and cash equivalents:
Beginning of period	3,451,761	21,716,077
End of period	4,569,038	7,611,210
Cash paid for:
Taxes	6,006	5,708
Interest	4,057	0
Non-cash investing and financing activities:
Property and equipment costs included in accounts payable and accrued expense	53,065	35,849
Acquisition of patents included in accounts payable	45,371	0
Deferred offering costs reclassified to additional paid-in-capital	13,283	1,586
Conversion of convertible notes into common stock	85,000	0
Prepaid insurance financed with promissory notes	276,489	0
June 2025 Financing [Member]
Cash flows from financing activities:
Proceeds from the issuance of common stock	4,510,001	0
Issuance costs	(804,940)	0
Non-cash investing and financing activities:
Issuance of warrants for underwriter commission	56,035	0
August 2025 Financing [Member]
Cash flows from financing activities:
Proceeds from the issuance of common stock	7,998,826	0
Issuance costs	(930,132)	0
Non-cash investing and financing activities:
Issuance of warrants for underwriter commission	$ 97,612	$ 0